SCHEMBL30396556

SCHEMBL30396556

O=C(O)c1cc2c(Cl)ccc(-c3ccccc3)c2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RHEB Q15382 4/20 0.55
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ FEN1 P39748 1/20 0.45
▸ EIF4A3 P38919 1/20 0.45
▸ PRKAB2 O43741 2/20 0.43
▸ PRKAG1 P54619 2/20 0.43
▸ PRKAA2 P54646 2/20 0.43
▸ PRKAA1 Q13131 2/20 0.43
▸ PRKAG3 Q9UGI9 2/20 0.43
▸ PRKAG2 Q9UGJ0 2/20 0.43
▸ PRKAB1 Q9Y478 2/20 0.43
▸ FBP1 P09467 3/20 0.43
▸ GRIN1 Q05586 1/20 0.43
▸ DAO P14920 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8323011 0.85 GAA (0.44) RHEBALDH1A1MEN1KMT2AFEN1
SCHEMBL24105185 0.82 FEN1 (0.40) RHEBMEN1KMT2AFEN1EIF4A3
SCHEMBL3959096 0.82 EIF4A3 (0.53) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL30310764 0.82 EIF4A3 (0.53) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL22394891 0.76 IDO1 (0.65) RHEBEIF4A3GRIN1DAOIDO1
SCHEMBL30396542 0.75 HPGD (0.51) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL27318461 0.75 FEN1 (0.48) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL24189547 0.75 HPGD (0.51) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL29053569 0.73 HSD17B10 (0.61) RHEBALDH1A1HPGDHSD17B10MEN1
SCHEMBL20536074 0.73 RHEB (0.62) RHEBALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 — — EP disclosed
Send feedback